HDAC6 is a novel regulator of endothelial-to-mesenchymal transition in venous thrombosis
Marion Pilard, Virginie Gourdou‐Latyszenok, Lénaïck Gourhant…·Catherine A. Lemarié
This study identifies HDAC6 as a regulator of endothelial-to-mesenchymal transition (EndMT) in venous thrombosis, showing that inhibiting HDAC6 reduces thrombus size and EndMT markers.